Hypoxia: The Cornerstone of Glioblastoma
Glioblastoma is the most aggressive form of brain tumor in adults and is characterized by the presence of hypervascularization and necrosis, both caused by a hypoxic microenvironment. In this review, we highlight that hypoxia-induced factor 1 (HIF-1), the main factor activated by hypoxia, is an impo...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d74eba75d08d4042af97cc5a900b3566 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d74eba75d08d4042af97cc5a900b3566 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d74eba75d08d4042af97cc5a900b35662021-11-25T17:58:18ZHypoxia: The Cornerstone of Glioblastoma10.3390/ijms2222126081422-00671661-6596https://doaj.org/article/d74eba75d08d4042af97cc5a900b35662021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12608https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Glioblastoma is the most aggressive form of brain tumor in adults and is characterized by the presence of hypervascularization and necrosis, both caused by a hypoxic microenvironment. In this review, we highlight that hypoxia-induced factor 1 (HIF-1), the main factor activated by hypoxia, is an important driver of tumor progression in GB patients. HIF-1α is a transcription factor regulated by the presence or absence of O<sub>2</sub>. The expression of HIF-1 has been related to high-grade gliomas and aggressive tumor behavior. HIF-1 promotes tumor progression via the activation of angiogenesis, immunosuppression, and metabolic reprogramming, promoting cell invasion and survival. Moreover, in GB, HIF-1 is not solely modulated by oxygen but also by oncogenic signaling pathways, such as MAPK/ERK, p53, and PI3K/PTEN. Therefore, the inhibition of the hypoxia pathway could represent an important treatment alternative in a disease with very few therapy options. Here, we review the roles of HIF-1 in GB progression and the inhibitors that have been studied thus far, with the aim of shedding light on this devastating disease.Marta DomènechAinhoa HernándezAndrea PlajaEva Martínez-BalibreaCarmen BalañàMDPI AGarticleglioblastomahypoxiaHIF-1HIF-1 inhibitorsBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12608, p 12608 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
glioblastoma hypoxia HIF-1 HIF-1 inhibitors Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
glioblastoma hypoxia HIF-1 HIF-1 inhibitors Biology (General) QH301-705.5 Chemistry QD1-999 Marta Domènech Ainhoa Hernández Andrea Plaja Eva Martínez-Balibrea Carmen Balañà Hypoxia: The Cornerstone of Glioblastoma |
description |
Glioblastoma is the most aggressive form of brain tumor in adults and is characterized by the presence of hypervascularization and necrosis, both caused by a hypoxic microenvironment. In this review, we highlight that hypoxia-induced factor 1 (HIF-1), the main factor activated by hypoxia, is an important driver of tumor progression in GB patients. HIF-1α is a transcription factor regulated by the presence or absence of O<sub>2</sub>. The expression of HIF-1 has been related to high-grade gliomas and aggressive tumor behavior. HIF-1 promotes tumor progression via the activation of angiogenesis, immunosuppression, and metabolic reprogramming, promoting cell invasion and survival. Moreover, in GB, HIF-1 is not solely modulated by oxygen but also by oncogenic signaling pathways, such as MAPK/ERK, p53, and PI3K/PTEN. Therefore, the inhibition of the hypoxia pathway could represent an important treatment alternative in a disease with very few therapy options. Here, we review the roles of HIF-1 in GB progression and the inhibitors that have been studied thus far, with the aim of shedding light on this devastating disease. |
format |
article |
author |
Marta Domènech Ainhoa Hernández Andrea Plaja Eva Martínez-Balibrea Carmen Balañà |
author_facet |
Marta Domènech Ainhoa Hernández Andrea Plaja Eva Martínez-Balibrea Carmen Balañà |
author_sort |
Marta Domènech |
title |
Hypoxia: The Cornerstone of Glioblastoma |
title_short |
Hypoxia: The Cornerstone of Glioblastoma |
title_full |
Hypoxia: The Cornerstone of Glioblastoma |
title_fullStr |
Hypoxia: The Cornerstone of Glioblastoma |
title_full_unstemmed |
Hypoxia: The Cornerstone of Glioblastoma |
title_sort |
hypoxia: the cornerstone of glioblastoma |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/d74eba75d08d4042af97cc5a900b3566 |
work_keys_str_mv |
AT martadomenech hypoxiathecornerstoneofglioblastoma AT ainhoahernandez hypoxiathecornerstoneofglioblastoma AT andreaplaja hypoxiathecornerstoneofglioblastoma AT evamartinezbalibrea hypoxiathecornerstoneofglioblastoma AT carmenbalana hypoxiathecornerstoneofglioblastoma |
_version_ |
1718411834993672192 |